Literature DB >> 15365005

Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000.

Muhamed-Kheir Taha1, Dario Giorgini, Magaly Ducos-Galand, Jean-Michel Alonso.   

Abstract

The occurrence of a clonal outbreak of serogroup W135 (of the electrophoretic type 37 [ET-37] clonal complex) meningococcal disease among Hajj pilgrims in 2000 has led to enhanced surveillance of the evolution of this particular serogroup, formerly considered rare, in invasive infections. Since the first case of meningococcal disease due to a serogroup W135 strain was detected in France in 1994, all isolates were characterized phenotypically. We further used phenotypic and genotypic approaches to type the 101 serogroup W135 strains isolated from patients with invasive meningococcal diseases in France in 2001 and 2002. Overall, 55% of these isolates had Hajj strain-related phenotypes (60 and 52% in 2001 and 2002, respectively), although only 45% belonged to the ET-37 clonal complex. Moreover, pulsed-field gel electrophoresis of the ET-37 clonal complex isolates showed that only 32% of the serogroup W135 isolates were indistinguishable from the 2000 Hajj-related strain. Our results suggest the continuous emergence of new genetic lineages of serogroup W135 independently of the 2000 global outbreak.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365005      PMCID: PMC516311          DOI: 10.1128/JCM.42.9.4158-4163.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis.

Authors:  P Zhu; A van der Ende; D Falush; N Brieske; G Morelli; B Linz; T Popovic; I G Schuurman; R A Adegbola; K Zurth; S Gagneux; A E Platonov; J Y Riou; D A Caugant; P Nicolas; M Achtman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

2.  Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger.

Authors:  Muhamed-Kheir Taha; Isabelle Parent Du Chatelet; Martin Schlumberger; Idrissa Sanou; Saacou Djibo; François de Chabalier; Jean-Michel Alonso
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001.

Authors:  Susan J M Hahné; Steve J Gray; Natasha S Crowcroft; Tom Nichols; Edward B Kaczmarski; Mary E Ramsay
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

4.  Comparison of serogroup W-135 meningococci isolated in Sweden during a 23-year period and those associated with a recent hajj pilgrimage.

Authors:  P Mölling; A Bäckman; P Olcén; H Fredlund
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

5.  Meningococcal disease, serogroup W135, Burkina Faso. Preliminary report, 2002.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2002-05-03

6.  Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex.

Authors:  Leonard W Mayer; Michael W Reeves; Nasser Al-Hamdan; Claudio T Sacchi; Muhamed-Kheir Taha; Gloria W Ajello; Susanna E Schmink; Corie A Noble; Maria Lucia C Tondella; Anne M Whitney; Yagoub Al-Mazrou; Mohammed Al-Jefri; Amin Mishkhis; Sameer Sabban; Dominique A Caugant; Jairam Lingappa; Nancy E Rosenstein; Tanja Popovic
Journal:  J Infect Dis       Date:  2002-05-17       Impact factor: 5.226

7.  [Clonal spread of Neisseria meningitidis W135].

Authors:  M K Taha; A Antignac; P Renault; A Perrocheau; D Levy-bruhl; P Nicolas; J M Alonso
Journal:  Presse Med       Date:  2001-10-27       Impact factor: 1.228

8.  Recent increase in meningitis Caused by Neisseria meningitidis serogroups A and W135, Yaoundé, Cameroon.

Authors:  Marie-Christine Fonkoua; Muhamed-Kheir Taha; Pierre Nicolas; Patrick Cunin; Jean-Michel Alonso; Raymond Bercion; Jeanne Musi; Paul M V Martin
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

Review 9.  Population genetics and molecular epidemiology of Neisseria meningitidis.

Authors:  D A Caugant
Journal:  APMIS       Date:  1998-05       Impact factor: 3.205

10.  Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.

Authors:  T Popovic; C T Sacchi; M W Reeves; A M Whitney; L W Mayer; C A Noble; G W Ajello; F Mostashari; N Bendana; J Lingappa; R Hajjeh; N E Rosenstein
Journal:  Emerg Infect Dis       Date:  2000 Jul-Aug       Impact factor: 6.883

View more
  25 in total

1.  Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains.

Authors:  Amanda J Beddek; Ming-Shi Li; J Simon Kroll; T William Jordan; Diana R Martin
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

Review 2.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Multilocus sequence typing of Neisseria meningitidis directly from clinical samples and application of the method to the investigation of meningococcal disease case clusters.

Authors:  Andrew Birtles; Katie Hardy; Stephen J Gray; Suzanne Handford; Edward B Kaczmarski; Valerie Edwards-Jones; Andrew J Fox
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

4.  Evolutionary changes in antimicrobial resistance of invasive Neisseria meningitidis isolates in Belgium from 2000 to 2010: increasing prevalence of penicillin nonsusceptibility.

Authors:  Sophie Bertrand; Françoise Carion; René Wintjens; Vanessa Mathys; Raymond Vanhoof
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

5.  Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age.

Authors:  Y Al-Mazrou; M Khalil; R Borrow; P Balmer; J Bramwell; G Lal; N Andrews; M Al-Jeffri
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

6.  Neisseria meningitidis ST-11 clonal complex bearing capsule serogroups B, C, or W in Brazil.

Authors:  David E Barroso; Terezinha M P P Castiñeiras; Adriana C Cabral; Ana C P Vicente; Maria C Rebelo; Elaine O Cerqueira; Mary M Tulenko; Jane W Marsh; Mary G Krauland; Lee H Harrison
Journal:  J Infect       Date:  2013-01-12       Impact factor: 6.072

7.  Neisseria adhesin A variation and revised nomenclature scheme.

Authors:  Stefania Bambini; Matteo De Chiara; Alessandro Muzzi; Marirosa Mora; Jay Lucidarme; Carina Brehony; Ray Borrow; Vega Masignani; Maurizio Comanducci; Martin C J Maiden; Rino Rappuoli; Mariagrazia Pizza; Keith A Jolley
Journal:  Clin Vaccine Immunol       Date:  2014-05-07

8.  Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil.

Authors:  Ana Paula S Lemos; Lee H Harrison; Melina Lenser; Claudio T Sacchi
Journal:  J Infect       Date:  2010-01-06       Impact factor: 6.072

9.  Interlaboratory comparison of PCR-based methods for detection of penicillin G susceptibility in Neisseria meningitidis.

Authors:  Muhamed-Kheir Taha; Maria Leticia Zarantonelli; Arianna Neri; Rocío Enriquez; Julio A Vázquez; Paola Stefanelli
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

10.  Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003.

Authors:  Judith E Mueller; Lassana Sangaré; Berthe-Marie Njanpop-Lafourcade; Zekiba Tarnagda; Yves Traoré; Seydou Yaro; Raymond Borrow; Bradford D Gessner; Pierre Nicolas
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.